drugset / Trial / NCT06050044

Intrathecal Injection of Hyperbaric Bupivacaine Versus a Mixture of Hyperbaric and Isobaric Bupivacaine in Patients Undergoing Lower Abdominal Surgery

NCT06050044 ↗

Completed 50 enrolled Helwan University
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to compare the effects of intrathecal injection of hyperbaric bupivacaine versus injection of hyperbaric and isobaric bupivacaine in patients undergoing lower abdominal surgery.

Timeline

Start
2022-05-01
Primary completion
2023-07-01
Completion
2023-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 10 mg Intrathecal
Subject Bupivacaine Other / unclassified 20 mg Intrathecal

Indications

No indication recorded.